Posted in | News | Business | Mining

Inco Board Recommends Shareholders Accept Offer from CVRD

Inco Limited today announced that its Board of Directors has recommended that Inco shareholders tender their shares to the offer made by Companhia Vale do Rio Doce (“CVRD”) to purchase all of the outstanding common shares of Inco at a price of Cdn. $86.00 in cash per share.

“We are satisfied that the CVRD offer of Cdn. $86.00 per share represents compelling value for our shareholders,” said Chairman and CEO Scott Hand. “CVRD is the third company that has made an offer for Inco, and those companies have announced a total of six bids between them since early May. We believe this process has brought about a very positive outcome for Inco shareholders, and we recommend that they tender to the CVRD offer.”

In addition to the value of the CVRD offer, Inco’s Board and management believe that CVRD represents an attractive partner for Inco. “We have great respect for the quality of their management team and for what they have accomplished as a company,” Mr. Hand added.

“Assuming CVRD is successful in their acquisition, we plan to assist them in every way we can to ensure the smoothest possible integration of our two companies, and a successful transition to create a new world leader in mining and metals,” he said.

CVRD has obtained its required regulatory clearances from the Canadian Competition Bureau and the United States competition authorities but it has yet to obtain clearances from the European Commission and Investment Canada.

In connection with Board’s recommendation regarding the CVRD Offer, the Company will file a Notice of Change to Directors’ Circular with Canadian securities regulatory authorities and an amendment to Solicitation/Recommendation Statement on Schedule 14D-9 (the “CVRD 14D-9”) with the United States Securities and Exchange Commission (the “SEC”). The Notice of Change to Directors’ Circular will also be mailed to Inco shareholders. Inco shareholders are urged to read the Notice of Change to Directors’ Circular and the CVRD 14D-9 and any amendments thereto because they contain important information.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.